SC
TAK icon

Syon Capital’s Takeda Pharmaceutical TAK Stock Holding History

Syon Capital’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$729K Sell
45,459
-6,185
-12% -$102K 0.03% 470
2026
Q1 		$956K Buy
51,644
+8,513
+20% +$149K 0.05% 323
2025
Q4 		$672K Sell
43,131
-16,125
-27% -$231K 0.03% 446
2025
Q3 		$868K Buy
59,256
+25,275
+74% +$375K 0.05% 305
2025
Q2 		$525K Buy
33,981
+6,025
+22% +$89K 0.03% 363
2025
Q1 		$416K Sell
27,956
-8,724
-24% -$122K 0.03% 344
2024
Q4 		$486K Sell
36,680
-25,626
-41% -$352K 0.04% 291
2024
Q3 		$886K Buy
+62,306
New +$884K 0.08% 182

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Syon Capital's TAK Position: Q2 2026 in Review

Syon Capital reduced its Takeda Pharmaceutical (TAK) stake by 12% in Q2 2026, selling an estimated $102K and leaving 45,459 shares worth $729K. The position accounts for 0.03% of the portfolio, ranked #470.

Syon Capital first reported a position in TAK in Q3 2024 and has held it in 8 quarters since. The position peaked at $956K in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Syon Capital held 45,459 shares of Takeda Pharmaceutical worth $729K as of Q2 2026.
  • Syon Capital sold 6,185 Takeda Pharmaceutical shares in Q2 2026, an estimated $102K.
  • Takeda Pharmaceutical made up 0.03% of Syon Capital's portfolio in Q2 2026, its #470 holding.
  • Syon Capital first reported a position in Takeda Pharmaceutical in Q3 2024 and has held it in 8 quarters since.
  • Syon Capital's Takeda Pharmaceutical position peaked at $956K in Q1 2026.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.